According to the Sataloff definition of pCR, 95 patients (30.4%) achieved a pCR with no significant difference between patients having HR+ and/or HER2+ tumours compared to TN tumours (60 [27.8%] versus 35 [36.5%]; p = 0.12). Here, ERBB2 is linked to neoplasm.